Skip to content

In the BioHarmony Drug Report Database

Inamrinone

Inocor (inamrinone) is a small molecule pharmaceutical. Inamrinone was first approved as Inocor on 1984-07-31. It is used to treat cardiogenic shock, dilated cardiomyopathy, heart failure, and low cardiac output in the USA. The pharmaceutical is active against cGMP-inhibited 3',5'-cyclic phosphodiesterase A and cGMP-inhibited 3',5'-cyclic phosphodiesterase B.
Trade Name Inocor
Common Name Inamrinone
Indication cardiogenic shock, dilated cardiomyopathy, heart failure, low cardiac output
Drug Class Cardiotonics (amrinone type)
Inamrinone
Get full access now